BELLUS Health (BLU) Competitor Comparison
We are evaluating the key criteria listed to compare BELLUS Health (BLU) against its competitors in the Biotechnology industry.
Market Capitalization
87 / 368Gross Profits
151 / 278Total Revenue
282 / 300EBITDA
191 / 337Free Cashflow
227 / 352Quick Ratio
9 / 357Earnings per Share
105 / 359Dividend yield
0 / 6Total Cash
108 / 358Performance 3 years
16 / 368Performance 5 years
11 / 368Performance 10 years
7 / 368Linearity 3 years
367 / 368Linearity 5 years
358 / 368Linearity 10 years
351 / 368Total Rank
218 / 368Dividend Rank
57 / 368Valuation Rank
188 / 368Piotroski Rank
180 / 368Muliplier Rank
290 / 368Total Revenue - BLU ranking 282 / 300
Obligatory risk notice
We would like to point out that the contents of this website are for general information purposes only and do not constitute recommendations for the purchase or sale of specific financial instruments, and therefore do not constitute investment advice. In particular, marketstorylabs.com and its creators cannot assess the extent to which information / recommendations made on the pages correspond to your investment objectives, your risk tolerance and your ability to bear losses. Therefore, if you make any investment decisions based on information on the site, you do so solely on your own responsibility and at your own risk. This in turn means that neither marketstorylabs.com nor its creators are liable for any losses incurred as a result of investment decisions based on the information on the marketstorylabs.com website or other media used.